Compare AstraZeneca plc (AZN) vs Realty Income Corp (O) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
AstraZeneca plc vs Realty Income Corp — how do they compare? AstraZeneca plc trades at $158.42 (market cap $250.84B), while Realty Income Corp trades at $61.99 (market cap $58.56B). The key difference: AstraZeneca plc is far larger — about 4.3× Realty Income Corp's market cap, and Realty Income Corp pays the higher dividend (5.25%). Which is the better fit depends on your goals.
| AZN | O | |
|---|---|---|
Market Cap | $250.84B | $58.56B |
Sector | Health | Real Estate |
52-Week High | $209.48 | $67.56 |
52-Week Low | $147.06 | $55.93 |
Enterprise Value | $278.12B | $89.19B |
Dividend Yield | 1.97% | 5.25% |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About AstraZeneca plc
A merger between Astra of Sweden and Zeneca Group of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across several major therapeutic classes, including gastrointestinal, diabetes, cardiovascular, respiratory, cancer, and immunology. The majority of sales come from international markets with the United States representing close to one third of its sales.
Read more on AZN →About Realty Income Corp
Realty Income owns roughly 11,400 properties, most of which are freestanding, single-tenant, triple-net-leased retail properties. Its properties are located in 49 states and Puerto Rico and are leased to 250 tenants from 47 industries. Recent acquisitions have added industrial, office, manufacturing, and distribution properties, which make up roughly 17% of revenue.
Read more on O →
